Chief Executive Officer @ Souvien Bio (June 2020 - February 2021)
Chief Executive Officer @ Epigenetics Division of Juvenescence (June 2020 - February 2021)
Director Board of Directors @ (June 2020 - Present)
Chief Executive Officer @ (April 2017 - June 2020)
Director Board of Directors @ (May 2018 - Present)
Neuroscience Therapeutic Area Lead, Clinical Development and Operations @ (April 2014 - November 2016)
Head of Portfolio, Strategy and Communications, Neuroscience Research @ (September 2010 - April 2014)
Senior Director, Worldwide Research and Development @ (January 2010 - September 2010)
Director, Strategic Management Group @ (May 2008 - January 2010)
Associate Director, Therapeutics; Neuroscience Program Leader @ (April 2007 - April 2008)
Management Consultant @ (March 2005 - April 2007)
PHD Student, Pharmacology and Neuroscience @ (August 2000 - August 2004)
Ellen Donnelly Education
Yale University School of Medicine
Doctor of Philosophy (Pharmacology, Neuroscience)
2000-2004
The George Washington University
(Molecular Biology)
1999-2000
Iowa State University
Bachelor of Science (Genetics, French)
1992-1996
Ellen Donnelly Skills
Business Strategy
Neuroscience
Lifesciences
Clinical Research
Biotechnology
Pharmaceutical Industry
Clinical Trials
Drug Development
Clinical Development
Healthcare
Life Sciences
Mergers
Strategic Planning
Medical Devices
Strategy
Pharmacology
Drug Discovery
Ellen Donnelly Summary
Ellen Donnelly, based in United States, is currently a Chief Executive Officer at Abliva Ab. Ellen Donnelly brings experience from previous roles at Souvien Bio, Epigenetics Division of Juvenescence and Dilaforette Ab. Ellen Donnelly holds a 2000 - 2004 Doctor of Philosophy in Pharmacology, Neuroscience @ Yale University School of Medicine. With a robust skill set that includes Business Strategy, Neuroscience, Lifesciences, Clinical Research, Biotechnology and more. Ellen Donnelly has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ellen Donnelly?
Find contact details for 700 million professionals.